• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核酸扩增检测、抗原免疫荧光分析与体外感染性在 SARS-CoV-2 诊断中的比较。

Comparison between nucleic acid amplification tests, antigen immunofluorescence assay, and in vitro infectivity in SARS-CoV-2 diagnosis.

机构信息

Institute for Maternal and Child Health IRCCS Burlo Garofolo, 34137, Trieste, Italy.

Division of Laboratory Medicine, University Hospital Giuliano Isontina (ASU GI), 34128, Trieste, Italy.

出版信息

Braz J Microbiol. 2022 Sep;53(3):1271-1277. doi: 10.1007/s42770-022-00758-6. Epub 2022 Apr 21.

DOI:10.1007/s42770-022-00758-6
PMID:35446012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9022615/
Abstract

The number of SARS-CoV-2 detection tests requested to the laboratories has dramatically increased together with an urgent need to release reliable responses in a very short time. The two options taken into consideration and analyzed in the current study were the point-of-care test (POCT) based on the nucleic acid amplification test (NAAT) and the Antigen (Ag) rapid test. The POCT-NAAT-based assay was compared with a rapid antigen test of nasopharyngeal swab samples. If the specimen tested positive, it was followed by viral load quantification and by the functional assessment of the residual infectivity. When the initial cycle threshold (Ct) was below 20 (100%), and in the range of 20-25 (92%) and of 25-30 (88%), a great concordance between the POCT-NAAT and the Ag test was observed. Moreover, the positivity of the antigen test was well correlated to a successful infection in vitro (78%), with greater concordance when the initial Ct below 20 or above 35 (100%) and in the range 20-25 (83%). Our findings showed that most of the swabs which tested positive using the antigen test were able to infect the cells in vitro, suggesting that probably only these samples hold residual infectivity and therefore an increased risk of virus transmission at the moment of being tested.

摘要

随着对实验室进行的 SARS-CoV-2 检测数量的急剧增加,迫切需要在极短的时间内发布可靠的结果。在当前的研究中,考虑并分析了两种选择,即基于即时检测(POCT)的核酸扩增测试(NAAT)和抗原(Ag)快速检测。将基于 POCT-NAAT 的检测与鼻咽拭子样本的快速抗原检测进行了比较。如果标本检测呈阳性,则进行病毒载量定量检测和剩余传染性的功能评估。当初始循环阈值(Ct)低于 20(100%)、在 20-25(92%)和 25-30(88%)范围内时,POCT-NAAT 和 Ag 检测之间观察到高度一致性。此外,抗原检测的阳性结果与体外成功感染密切相关(78%),当初始 Ct 低于 20 或高于 35(100%)以及在 20-25 范围内时,一致性更高(83%)。我们的研究结果表明,使用抗原检测呈阳性的大多数拭子都能够在体外感染细胞,这表明可能只有这些样本具有残留的传染性,因此在检测时存在增加的病毒传播风险。

相似文献

1
Comparison between nucleic acid amplification tests, antigen immunofluorescence assay, and in vitro infectivity in SARS-CoV-2 diagnosis.核酸扩增检测、抗原免疫荧光分析与体外感染性在 SARS-CoV-2 诊断中的比较。
Braz J Microbiol. 2022 Sep;53(3):1271-1277. doi: 10.1007/s42770-022-00758-6. Epub 2022 Apr 21.
2
Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection.病毒载量可能会影响鼻拭子在用于检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的核酸扩增试验和定量抗原试验中的诊断性能。
J Infect Chemother. 2022 Nov;28(11):1590-1593. doi: 10.1016/j.jiac.2022.07.023. Epub 2022 Aug 8.
3
Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France.法国 COVID-19 疫情第二波期间 VitaPCR™ SARS-CoV-2 检测试剂盒的表现。
J Med Virol. 2021 Jul;93(7):4351-4357. doi: 10.1002/jmv.26950. Epub 2021 Apr 1.
4
Comparison of Antigen Tests and qPCR in Rapid Diagnostics of Infections Caused by SARS-CoV-2 Virus.抗原检测与 qPCR 在 SARS-CoV-2 病毒感染快速诊断中的比较。
Viruses. 2021 Dec 23;14(1):17. doi: 10.3390/v14010017.
5
Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.新型冠状病毒抗原检测在儿科人群大规模筛查中的可行性和有效性评估及其与病毒载量动力学的相关性。
Viruses. 2021 Oct 14;13(10):2071. doi: 10.3390/v13102071.
6
Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort.Sars-Cov-2 抗原检测基于病毒培养预测传染性:对大样本队列的抗原、PCR 病毒载量和病毒培养检测的比较。
Clin Microbiol Infect. 2023 Jan;29(1):94-100. doi: 10.1016/j.cmi.2022.07.010. Epub 2022 Jul 19.
7
Evaluation of the new 2.0 version of the Roche SARS-CoV-2 Rapid Antigen Test.罗氏新型 2.0 版 SARS-CoV-2 抗原快速检测试剂评估。
J Virol Methods. 2023 Sep;319:114758. doi: 10.1016/j.jviromet.2023.114758. Epub 2023 May 30.
8
Performance of High Throughput SARS-CoV-2 Antigen Testing Compared to Nucleic Acid Testing.高通量 SARS-CoV-2 抗原检测与核酸检测的性能比较。
Lab Med. 2023 Mar 7;54(2):e54-e57. doi: 10.1093/labmed/lmac107.
9
Characteristics of the ID-NOW™ test for the rapid detection of SARS-CoV-2.用于快速检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的ID-NOW™检测的特点。
Epidemiol Mikrobiol Imunol. 2023 Winter;72(1):3-8.
10
Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests.抗原检测用于 COVID-19 诊断的性能:侧向流设备与基于核酸扩增检测的直接比较。
BMC Infect Dis. 2021 Aug 10;21(1):798. doi: 10.1186/s12879-021-06524-7.

引用本文的文献

1
Shedding of infectious SARS-CoV-2 despite vaccination.接种疫苗后仍有传染性 SARS-CoV-2 的脱落。
PLoS Pathog. 2022 Sep 30;18(9):e1010876. doi: 10.1371/journal.ppat.1010876. eCollection 2022 Sep.

本文引用的文献

1
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.雅培ID NOW新型冠状病毒肺炎快速分子检测法与赛沛Xpert Xpress新型冠状病毒检测法在干燥鼻拭子中的比较。
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115208. doi: 10.1016/j.diagmicrobio.2020.115208. Epub 2020 Sep 16.
2
Thoracic imaging tests for the diagnosis of COVID-19.用于诊断新型冠状病毒肺炎的胸部影像学检查
Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3.
3
Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.基于 SARS-CoV-2 核衣壳蛋白的免疫信息学分析与 COVID-19 疫苗靶点的鉴定
Front Immunol. 2020 Oct 28;11:587615. doi: 10.3389/fimmu.2020.587615. eCollection 2020.
4
Types of Assays for SARS-CoV-2 Testing: A Review.新型冠状病毒2019检测方法综述
Lab Med. 2020 Sep 1;51(5):e59-e65. doi: 10.1093/labmed/lmaa039.
5
Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.通过细胞培养测定病毒 RNA 载量作为管理工具,以将 SARS-CoV-2 患者从传染病病房中出院。
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061. doi: 10.1007/s10096-020-03913-9. Epub 2020 Apr 27.